IJPRD, 2014; Vol 5(12): February-2014 ( ) International Standard Serial Number

Similar documents
FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Studies on Carica Papaya Starch as a Pharmaceutical Excipient

Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Formulation and evaluation of immediate release salbutamol sulphate

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

Studies on Curcuma angustifolia Starch as a Pharmaceutical Excipient

Formulation and Evaluation

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Journal of Chemical and Pharmaceutical Research

DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN

Journal of Global Trends in Pharmaceutical Sciences Vol.2, Issue 4, pp , Oct -Dec 2011

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants

FORMULATION AND EVALUATIONOF AMOXYCILLIN: THREE-LAYER GUAR GUM MATRIX TABLET

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Preparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums

Design and development of fast Melting Tablets of Terbutaline Sulphate

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Development and evaluation of controlled release mucoadhesive tablets of Tramadol Hydrochloride

Optimization of valsartan tablet formulation by 2 3 factorial design

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Pelagia Research Library

International Journal of Chemistry and Pharmaceutical Sciences

Maisammaguda, Dulapally, Secundrabad.

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

Formulation Development and Evaluation of Atorvastatin Calcium Tablets using Co-Processed Excipients

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Fabrication and evaluation of Nimesulide Azadirachta indica fruit mucilage based sustained release matrix tablets

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Venkateswara Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets

Available online Research Article

Formulation Development and Evaluation of Antidiabetic Polyherbal Tablet

Pharmacologyonline 2: (2010) Newsletter Rathi et al.

Formulation and evaluation of sublingual tablets of lisinopril

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil

Formulation and In-Vitro Evaluation of Leflunomide Tablet with Enhanced Dissolution

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets

J.Ayyappan et al, /J. Pharm. Sci. & Res. Vol.2 (7), 2010,

Formulation and evaluation of oral dispersible tablets of aripiprazole

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

COMPARATIVE IN VITRO EVALUATION OF COMMERCIALLY AVAILABLE PANTOPRAZOLE DELAYED RELEASE TABLETS

Asian Journal of Biochemical and Pharmaceutical Research

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

FORMULATION AND IN VITRO EVALUATION OF FAMOTIDINE FLOATING TABLETS BY LIPID SOLID DISPERSION SPRAY DRYING TECHNIQUE

International Journal of Pharma and Bio Sciences. Preparation and Evaluation of Aegle marmelos Gum as Tablet Binder

Formulation and evaluation of oro-dispersible tablets of lafutidine

Global College of Pharmacy, Kahnpur Khui, Tehsil Anandpur Sahib, Distt.- Ropar, Punjab, India

Available online through

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Optimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS

COMPARATIVE EFFECT OF DIFFERENT HIGH FUNCTIONALITY EXCIPIENTS ON VARIOUS CHARACTERISTICS OF VARDENAFIL HCL TABLETS (BCS II DRUG)

IJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

Available Online through Research Article

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on Research Article

Evaluation of Terminalia randii Baker F. gum as a disintegrant in paracetamol tablet formulation

International Journal of Medicine and Pharmaceutical Research

Available Online through

Formulation and development of orodispersible tablet of Memantine HCl by sublimation approach

A NOVEL BINDING AGENT FOR PHARMACEUTICAL FORMULATION FROM CASSIA ROXBURGHII SEEDS

EXTRACTION, ISOLATION AND EVALUATION TRIGONELLA FOENUM-GRAECUM AS MUCOADHESIVE AGENT FOR NASAL GEL DRUG DELIVERY

Formulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate

Vinod Doharey et al, /J. Pharm. Sci. & Res. Vol.2(2), 2010, 64-68

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

The purpose of the present investigation was to design a formulation of orodispersible tablets of Etoricoxib by adopting

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page:

Formulation Development of Nimesulide Tablets by Wet Granulation and Direct Compression Methods Employing Starch Citrate

FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE

Plantago Ovata Mucilage: A Natural Release Rate Retardant In Aceclofenac Tablet Formulation

Journal of Global Trends in Pharmaceutical Sciences. Journal home page:

FORMULATION DEVELOPMENT AND EVALUATION OF COLON TARGETED DOSAGE FORM OF IBUPROFEN

Formulation Development and Evaluation of Sitagliptin Floating Tablets Containing Natural Polymer

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

DEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED RELEASE AGENT FOR TABLETS

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Formulation and Evaluation of Sustain Release Bilayer Tablets of Metformin and Gliclazide

Volume: I: Issue-2: Aug-Oct ISSN NOVEL APPROACH IN FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE

Available Online through

Virendra Singh et.al, IJPRR 2014; 3(11) 22

IJRPC 2014, 4(2), Vinod Kumar et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS

May Vol: 06 Issue: 01 (1-12)

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES

FORMULATION AND EVALUATION OF DILTIAZEM HYDROCHLORIDE COLON TARGETED TABLETS

Asian Journal of Research in Biological and Pharmaceutical Sciences

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

Feasibility of using natural gums for development of sustained release matrix tablet of itopride

Formulation Development and Evaluation of Sustained Release Matrix Tablets of Guaiphenesin

Formulation Development and Evaluation of Cholecalciferol (Vitamin D3) Granules and Tablets

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

Transcription:

IJPRD, 2014; Vol 5(12): February-2014 (101 107) International Standard Serial Number 0974 9446 -------------------------------------------------------------------------------------------------------------------------------------------------- EXTRACTION AND CHARACTERIZATION OF MUCILAGE OBTAINED FROM LINUMUSITATISSIMUM AND ITS USE AS A BINDER IN TABLET FORMULATION Vandana K. Wankhede 1*, Rashmi S. Srivastava 1 *1 MET Institute Of Pharmacy, MET Complex, Bandra Reclamation, Bandra, Mumbai-400050 ABSTRACT The basic aim of present work was to extract the mucilage from Linum usitatissimum seeds using suitable method and to check its suitability as tablet binder. The mucilage was extracted from the seeds by maceration technique using water and then precipitated with acetone in 1:3 proportion (yield 9-12 % w/w). The physicochemical properties of mucilage i.e. moisture content, solubility, ph, swelling index, water absorption capacity and ash values were determined. The granules were prepared by Wet Granulation technique using Ibuprofen as model and mucilage as binder in concentrations ranging from 1-9 % w/w. The prepared granules were free flowing and the compressed tablets showed good hardness and friability as compared to starch and thereby confirming the mechanical resistance of the tablets. Invitro dissolution profiles of tablets were carried out in phosphate buffer ph 7.2 and were compared with starch (10%w/w) as standard. The evaluation data suggested that the tablets prepared using Linum usitatissimum mucilage showed good binding ability and comparable dissolution profile as that of the standard. The evaluation parameters also comply with pharmacopoeial limits. Hence an attempt was made to formulate conventional tablets using mucilage obtained from natural source with better binding ability. Correspondence to Author Vandana K. Wankhede MET Institute Of Pharmacy, MET Complex, Bandra Reclamation, Bandra, Mumbai-400050 Email: w_vandana@yahoo.com Key words: Linum usitatissimum, mucilage, binder, Ibuprofen, conventional tablets INRODUCTION Binders are added to tablet formulation to impart plasticity and thus increase the interparticulate bonding strength within the tablet. Binders are agents employed to impart cohesiveness to the granules. This ensures the tablet remains intact after compression as well as improves the flow properties by the formulation of granules of derived hardness and size. The choice of a suitable binder for a tablet formulation requires extensive 101

knowledge of the relative importance of binder properties, for enhancing the strength of the tablet and also of the interactions between the various materials constituting a tablet. Fillers usually do not have good binding capacity, binder is either added in dry mix or in granulating liquid, binder forms a matrix with the fillers and gets embedded in it, on drying binder forms glue which holds the particles together. The wet binder is the most important ingredient in the wet granulation process; most binders are hydrophilic & majority of them are soluble in water 1. Flaxseed, also known as linseed, is derived from the flax plant (Linum usitatissimum), of the family Linaceae, which is cultivated worldwide for its fiber and oil. Flaxseed contains 6% mucilage or soluble fibers, insoluble fibers 18%, 25% proteins, and 30-40% oil, with alpha-linolenic acid (ALA) making up about 50-60% of the total fatty acids 2. These plants contain natural polysaccharides which have been employed as food and pharmaceutical excipients because of their biocompatibility, biodegradability, easy availability and low cost. Flax seeds produce high viscosity mucilage at low concentration levels 3. The present study involves extraction of mucilage from seeds and its use as binder in tablets. The in vitro release studies were compared with standard binder. The study involves Ibuprofen as a model to formulate tablets. It is a non steroidal anti inflammatory (NSAID) used in pain, fever reduction and swelling. It has analgesic and anti pyretic properties. The is weakly acidic with high permeability because it remains 99.9% unionized in stomach. It is well absorbed orally and its half life is 1.8 2 hrs 4. MATERIALS AND METHODS: The seeds of Linum Usitatissimum were purchased from local market from Mumbai and authenticated at Ramnarain Ruia College, Matunga. Model Ibuprofen was obtained as gift sample from Aarti s limited, Tarapur. Lactose, talc, starch and magnesium stearate were obtained from S.D Fine Chemicals Pvt. Ltd. ISOLATION OF MUCILAGE: 100 gm flaxseeds were soaked in distilled water for 48 hrs for complete release of mucilage in water. The thick slimy solution was then boiled till there is formation of thick mass and separation of mucilage from the seeds. The solution is then vacuum filtered. Acetone was added to the filtrate for the precipitation of mucilage from the solution. The separated mucilage was then dried at 50 C for 2 to 3 hrs. It was then passed through sieve no. 60 and stored in dessicator until further use 5. EVALUATION OF MUCILAGE: I. Chemical characterization of mucilage: The chemical characterization of mucilage was done by Molisch test, ruthenium red test, iodine test and enzyme test 6. II. Physicochemical characterization of flaxseed mucilage: Description, odour, taste, texture, solubility, ph, loss on drying, water holding capacity, ash value, acid insoluble ash, swelling index 7. III. Pharmaceutical characterization of flaxseed mucilage: Bulk density, tapped density, angle of repose, Hausners ratio, compressibility index. FORMULATION AND EVALUATION OF IBUPROFEN TABLET: Formulation of ibuprofen tablets For the comparison of the flaxseed mucilage as binder, starch was used as a disintegrant in the prepared ibuprofen tablet. The composition of tablet formulation containing ibuprofen is given in table 4. Wet granulation and compression Tablets of ibuprofen were prepared by wet granulation method as per formula given in Table 4. Calculated amount of ibuprofen and excipients were blended and granulated using aqueous solution of mucilage. The wet mass was passed through no. 8 mesh. The wet granules were dried at 50 C for 3 h. the dried granules were again passed through sieve no. 12 to get uniform granules. The granules were then blended with magnesium stearate as lubricant and talc as glidant 102

and compressed using 12-mm punches in tableting machine 5. EVALUATION OF GRANULES: Angle of repose (θ) It is the maximum angle possible between the surface of pile of the powder and the horizontal plane. Fixed funnel method was used. A funnel was fixed with its tip at a given height (h), above a flat horizontal surface on which a graph paper was placed. Powder was carefully poured through a funnel till the apex of the conical pile just touches the tip of funnel. The angle of repose was then calculated using the formula, θ = tan-1(h/r) Where, θ = angle of repose, h = height of pile, r = radius of the base of the pile. Bulk density (D b ) It is the ratio of mass of the powder taken to its bulk volume. The bulk density depends on particle size distribution, shape and cohesiveness of particles. Accurately weighed quantity of powder was carefully poured into graduated measuring cylinder through large funnel and volume was measured which is called initial bulk volume. Bulk density is expressed in gm/cc and is given by, Db = M/Vo where,db = Bulk density (gm/cc), M =Mass of powder (g), V o = Bulk volume of powder (cc) Tapped density (D t ) Ten grams of powder was introduced into a clean, dry 100 ml measuring cylinder. The cylinder was then tapped 100 times from a constant height and tapped volume was read. It is expressed in gm/cc and is given by, D t = M/Vt Where, D t = Tapped density (gm/cc), M = Mass of powder (g), V t = Tapped volume of powder (cc) Compressibility Index An indirect method of measuring powder flow from bulk densities was developed by Carr. The percentage compressibility of powder was a direct measurement of the potential powder arch or the bridge strength and stability. Percent Compressibility Index of each formulation was calculated according to equation given below % Compressibility index = [(D t D o )/D t ] x 100. Where, D t = Tapped density, D o = Bulk density Hauser s ratio Hausner s ratio is an index of ease of powder flow; it is calculated by the following formula. Hausner s ratio = D t /D o, Where D t = Tapped density, D o = Bulk density. Evaluation of Powder Blends is shown in Table 6. EVALUATION OF TABLETS: Thickness and Diameter Control of physical dimension of the tablet such as thickness is essential for consumer acceptance and tablet uniformity. The thickness and diameter of the tablet was measured using vernier calipers. It is measured in mm. Weight uniformity test Twenty tablets from each batch were selected randomly and weight individually using a highly sensitive electronic balance. Their mean weights were calculated for each batch. Hardness The Monsanto hardness tester was used to determine the tablet hardness. The tablet was held between a fixed and moving jaw. Scale was adjusted to zero; load was gradually increased until the tablet fractured. The value of the load at that point gives a measure of hardness of the tablet. Hardness was expressed in kg/cm 2. Three tablets were randomly picked and hardness of the tablets was determined Content Uniformity Twenty tablets were weighed individually and powdered in mortar pestle, and an amount equivalent to 150 mg of Ibuprofen was extracted with 100 ml of phosphate buffer (ph 7.2) and sonicated for 10 min. The solution was filtered through a 0.45-µm syringe filter, and the content of ibuprofen in the solution was determined by UV spectrophotometer (Shimadzu V 630) at 221 nm after suitable dilution. Friability Tablet strength was tested by using Roche Friabilator. 20 tablets were weighed and placed in the friabilator and operated for 100 revolutions at 25 rpm for 4 min, tablets were taken out and 103

dedusted. The percentage weight loss was calculated by reweighing the tablets. The % friability was then calculated by, F = {(Wt initial) (Wt final)/(wt initial)} x 100 Disintegration time One tablet from each batch was taken in disintegration assembly and time taken for the tablets to pass through the mesh was observed. In Vitro Release Study: The in vitro release studies were conducted using USP type II apparatus; the dissolution media is comprised of phosphate buffer ph 7.2 (900 ml) kept at 37.0±0.5 C and 100 rpm. An aliquot of 5 ml was withdrawn and replaced with another 5 ml of fresh dissolution medium at various time intervals. The contents of ibuprofen in sample were determined by measuring absorbance at 221 nm in a UV-Visible spectrophotometer after suitable dilutions. The release study was performed in triplicates 8. RESULTS AND DISCUSSION: Flaxseed mucilage consists of dark brownish particles having characteristic odour which hydrate rapidly on contact with water to swell but is sparingly soluble in water. The ph of 1% (w/v) aqueous dispersion of the mucilage was found to be 6.0 6.5. The swelling index of mucilage was found to be 7.5 % (v/v). The mucilage showed a loss on drying of 11.11 % (w/w), the total ash contents were found to be 40% (w/w) and acidinsoluble ash 18% (w/w), respectively. The bulk density, tapped density, Carr s index, and Hausner ratio of the mucilage were 0.4630 g/ml, 0.602 g/ml, 0.2308 and 0.76. The loss on drying was well within official limits. The compressibility index and angle Table 1: Chemical characterization of mucilage Molisch test of repose indicated that the powder is having good flow with moderate compressibility Table (5) presents the results of characterization of granules of ibuprofen tablets. The angle of repose of the prepared granules remained between 28 and 30, indicating satisfactory flow properties. The other parameters for granules were also calculated and found to be within the acceptable limits. The compressed tablets showed good hardness and friability as compared with starch thereby confirming the mechanical resistance of tablets. The physical appearance, hardness, friability, weight variation, and content of all the tablet formulations were found to be satisfactory and reproducible (Table 6). It was observed that the increase in the concentration of mucilage in the formulation showed corresponding increase in the hardness of tablets, which may be attributed to the formation of stronger bonds and increase in binding capacity of mucilage. The content uniformity amongst different batches of tablets was found to be good and was more than 97%. CONCLUSION: The extraction process of mucilage from seeds of Linum Usitatissimum was easier, cheap and economical. It was observed from the results that tablets prepared using the flaxseed mucilage as binder showed significant hardness and friability. Thus, on the basis of the studies it can be concluded that the mucilage obtained from Linum Usitatissimum possesses significant binding properties and can be used as binder in pharmaceutical formulations. Test Procedure Observation Inference Take 100 mg dried mucilage powder. Add violet green colour is carbohydrate molisch reagent and conc. H 2 SO 4 on sides observed at the junction present of the test tube. of two layers. Ruthenium red test Take small quantity of mucilage powder and mount it on a slide with ruthenium red solution and observe under microscope Pink color develops mucilage present 104

Iodine test take 100 mg dried mucilage powder and add 1ml of 0.2N iodine solution. No color is observed in solution Polysaccharide present Enzyme test dissolve 100 mg dried mucilage powder in 20 ml distilled water. Add 0.5 ml of benzidine in alcohol (90%). Shake and allow to stand for few minutes No blue color change Enzyme absent Table 2: Physicochemical Characteristics of mucilage from seeds of Linum usitatissimum Sr. No. Tests Observations 1 Description Light brown powder Forms colloidal solution, soluble in Solubility 2 lukewarm water, Practically insoluble in ethanol, soluble in chloroform 3 Odour Characteristic. 4 Appearance Lustrous. 5 Identification a. Mounted in 96% ethanol b. Mounted in water Transparent angular masses. Particles swell 6 Melting range Decomposes above 2000c 7 PH (1%w/v) 6.2 8 Loss on drying 11.11% 9 Ash value 40 10 Acid insoluble ash. 18 11 Swelling index(ml) 7.5 12 Test for Tannins (Ferric chloride test) _ 13 Test for chloride (Silver-nitrate test) _ 14 Test for Sulphate (Barium chloride test) _ 15 Test for Saponin + 16 Test for steroid + 17 Test for foreign matter NMT 0.1 % 18 Percentage Yield 12%w/w 19 Water holding capacity 1.1gm/gm of water 20 Microbial load passes Table 3: Pharmaceutical characteristics of mucilage of seeds of Linum usitatissimum Sr.no Parameter Result 1 Loss on drying 11.11% 2 Angle of repose 28.35 3 Tapped density 0.602 4 Bulk density 0.4630 5 Compressibility Index 23.08 105

Table 4: Formulation of Tablets Formulation code (mg) F1 F2 F3 F4 F5 Ibuprofen 400 400 400 400 400 Flaxseed mucilage (%) 1 3 5 7 9 Lactose 156.5 144.5 132.5 120.5 108.5 Starch 25 25 25 25 25 Magnesium stearate 10 10 10 10 10 Talc 2.5 2.5 2.5 2.5 2.5 Total (mg) 600 600 600 600 600 Table 5: Evaluation of Granules Formulation code Angle of repose (Degrees) Bulk density (gm/ml) Tapped density (gm/ml) Hausners ratio Compressibility index (%) F1 28.72 0.60 0.71 0.84 15.0 F2 26.32 0.52 0.60 0.866 15.0 F3 28.48 0.51 0.59 0.864 13.5 F4 29.35 0.49 0.53 0.92 7.0 F5 30.12 0.49 0.53 0.92 7.0 TABLE 6: Evaluation of Tablets Formul Weight ation variation code (mg) Thickness (mm) Hardness (kg/cm 2 ) Disintegration time (mins) Friability (%) Drug content (%) F1 600±2 4.0 4.1 5 0.64 98.23 F2 600±4 3.8 4.6 10 0.55 97.55 F3 600±1 3.9 5.3 12 0.48 98.96 F4 600±2 4.1 5.5 25 0.45 95.44 F5 600±3 4.0 6 45 0.32 94.11 Table 7: In vitro dissolution of ibuprofen tablets containing different % of mucilage. Formulation Code Time in Min. F1 F2 F3 F4 F5 Starch Paste (10%) 0 0 0 0 0 0 0 15 80.12 60.23 15.14 14.44 8.98 16.47 30 95.06 75.33 24.33 25.35 12.14 23.52 45 100 88.57 38.14 30.32 25.63 45.69 60-95.08 58.98 45.63 33.47 54.58 75-98.21 70.65 56.78 40.44 68.47 106

90 - - 82.78 68.32 49.98 85.78 115 - - 95.96 77.98 55.63 91.63 120 - - 99.43 80.06 61.33 97.07 Fig. 1: In vitro dissolution of ibuprofen tablets containing different % of mucilage. F3 containing 5 % mucilage shows similar release profile as that of 10% starch. Cum % 120 100 80 60 40 20 Starch Paste(10 %) F1 F2 F3 ACKNOWLEDGEMENTS: The authors are thankful to Arti Drugs Pvt. Ltd. for gift sample of Ibuprofen. We also thank the Principal and Ms. Vrushali Keer, M.E.T. Institute of pharmacy, Bandra for immense help and support. REFERENCES 1. Patel S, Agrawal S, Lodhi B, Natural Binding Agents in Tablet Formulation, International Journal of Pharmaceutical & Biological Archives, 3, 2012, 466-473. 2. Handa SS and Kapoor VS, Textbook of Pharmacognosy, 2 nd edition, Vallabh prakashan, Delhi, 1989, 120, 257 3. Inamdar M, Abhang P, Abhang M, Isolation and evaluation of fenugreek, flaxseed, Mucilages and its use as a pharmaceutical binder, 4, Oct- 2012, 4766-4777. 4. Bomepudi S, Deveswaran R, Bharath S, Basavaraj BV and Madhavan V, Studies on 0 0 50 100 150 Time (min) ***** Vigna mungo mucilage as a pharmaceutical xcipient, Journal of Chemical and Pharmaceutical Research, 3, 2011, 18-25. 5. Shripad S, Amol A, Isolation of mucilage from flaxseeds and its use as a binder in manufacturing of tablet, International Journal of Pharmaceutical Research and Development, 4, November 2012, 064-069. 6. Girish K, Dhiren P, Vipul D, Vineet C, Gums And Mucilages : versatile excipients for pharmaceutical formulations, Asian Journal of Pharmaceutical Sciences, 4, 2009, 308-322. 7. Khandelwal KR, Practical Pharmacognosy, Techniques And Experiments, 9 th edition, Nirali Prakashan, Pune, 2012, 26, 150,157,159 8. Indian Pharmacopoeia, 6 th edition, Vol. 2, Govt. of India, Controller of Publications, New Delhi, 2010, 1482. 107